In particular, the DG focuses on the contribution of the healthcare industries to the European economy and the interactions between policies affecting research and development, market access, intellectual property, competition, and international trade.
Commission actions Since the adoption of the first legislation for the sector inthe EU has enacted various other pieces of legislation with the aim of achieving a single market for pharmaceuticals that also guarantees a high level of protection for public health. This is done through the EU system of pharmacovigilance.
Once a medicinal product has been authorised and placed on the EU market, its safety is monitored throughout its entire lifespan.
The EU has established the European Medicines Agency EMEA to help in this process by coordinating the scientific evaluation of the quality, safety, and efficacy of medicinal products undergoing an authorisation procedure.
This is to guarantee the highest possible level of animal health and to secure the availability of these products across the EU.
Documents Communication on the future of the pharmaceutical sector, available as part of the pharmaceutical package. The pharmaceutical sector also has one of the highest labour productivities in the EU.
Particular special rules are applied to ensure consumer protection from residue limits from pharmacologically active substances used in food-producing animals. In the case of adverse reactions that present an unacceptable level of risk under normal conditions of use, the product is rapidly withdrawn from the market.
Medicinal products for veterinary use must also be authorised at national or EU level before being placed on the EU market. Reports of the Pharmaceutical Committeean advisory Committee made of senior experts from EU countries entrusted with examining questions relating to proprietary medicinal products, and in particular, the preparation of proposals for Directives.
Medicinal products for human use and veterinary use All medicinal products for human use must be authorised at national or EU level before they can be placed on the EU market. More information on medicinal products for veterinary use DG Health and Consumers Ensuring competitiveness in the healthcare industries One of the main tasks of the Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs is to identify key issues that affect the competitiveness of the European healthcare industries and propose solutions in cooperation with stakeholders.
Special rules exist for the authorisation of medicinal products for paediatric use, orphan medicines, traditional herbal medicines, vaccines, and clinical trials.
Toys Healthcare Industries A vibrant EU pharmaceutical sector is essential to achieving a high level of public health protection and a competitive knowledge-based economy.
The Community Register which contains a list of all medicinal products for human and veterinary use, as well as orphan medicinal products, that have received a marketing authorisation through the centralised procedure.Industry challenges in Germany: Germany is a major player in the global medical device market, in terms of market reach and innovation, but the domestic market lagged behind other major European markets in recent years.
German manufacturers export their products to other markets to maintain growth. Internet of Things (IoT) Healthcare Market by Component (Implantable Sensor Devices, Wearable Sensor Devices, System and Software), Application (Patient Monitoring, Clinical Operation and Workflow Optimization, Clinical Imaging, Fitness and Wellness Measurement) - Global Opportunity Analysis and Industry Forecast, - Ensuring competitiveness in the healthcare industries One of the main tasks of the Directorate-General for Internal Market, Industry, Entrepreneurship, and SMEs is to identify key issues that affect the competitiveness of the European healthcare industries and propose solutions in cooperation with stakeholders.
EUROPE – Overview of medical device industry and basic healthcare statistics Below you will find basic demographic and healthcare market data on Europe, plus specific information about the medical device and healthcare industries.
Global medical devices market expected to reach $B by increasing healthcare expenditure and technology advancement. R&D investment, geographic distributions and product categories by device area in the global medical device market and industry.
Historical statistics cover the past three years and forecast data. MedTech Market in Europe 26 Foreword. It is with great pleasure that I present to you the edition of The European Medical Technology Industry In Figures.
These new statistics show that the medical technology industry continues to be one of Europe’s most diverse and innovative high- Medical Device any instrument, apparatus.Download